As of 2025-03-20, the Relative Valuation of Novocure Ltd (NVCR) is (80.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.32 USD, the upside of Novocure Ltd based on Relative Valuation is -514.9%.
The range of the Relative Valuation is (70.91) - (89.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 46.2x - 60.9x | 53.0x |
| Forward P/E multiples | 42.6x - 58.0x | 51.6x |
| Fair Price | (70.91) - (89.01) | (80.16) |
| Upside | -467.0% - -560.7% | -514.9% |
| Date | P/E |
| 2025-03-18 | -12.62 |
| 2025-03-17 | -12.77 |
| 2025-03-14 | -12.70 |
| 2025-03-13 | -13.08 |
| 2025-03-12 | -13.44 |
| 2025-03-11 | -13.90 |
| 2025-03-10 | -13.23 |
| 2025-03-07 | -13.15 |
| 2025-03-06 | -12.55 |
| 2025-03-05 | -12.48 |
| 2025-03-04 | -11.86 |
| 2025-03-03 | -12.00 |
| 2025-02-28 | -12.43 |
| 2025-02-27 | -12.54 |
| 2025-02-26 | -14.31 |
| 2025-02-25 | -13.69 |
| 2025-02-24 | -13.85 |
| 2025-02-21 | -14.40 |
| 2025-02-20 | -14.11 |
| 2025-02-19 | -14.22 |
| 2025-02-18 | -14.37 |
| 2025-02-14 | -14.65 |
| 2025-02-13 | -14.15 |
| 2025-02-12 | -13.93 |
| 2025-02-11 | -13.83 |
| 2025-02-10 | -14.11 |
| 2025-02-07 | -14.50 |
| 2025-02-06 | -14.95 |
| 2025-02-05 | -15.76 |
| 2025-02-04 | -15.43 |
| 2025-02-03 | -15.48 |
| 2025-01-31 | -15.98 |
| 2025-01-30 | -16.63 |
| 2025-01-29 | -16.64 |
| 2025-01-28 | -16.67 |
| 2025-01-27 | -16.54 |
| 2025-01-24 | -17.16 |
| 2025-01-23 | -17.61 |
| 2025-01-22 | -17.49 |
| 2025-01-21 | -17.57 |
| 2025-01-17 | -17.06 |
| 2025-01-16 | -16.96 |
| 2025-01-15 | -17.18 |
| 2025-01-14 | -17.10 |
| 2025-01-13 | -17.84 |
| 2025-01-10 | -17.89 |
| 2025-01-08 | -18.85 |
| 2025-01-07 | -18.91 |
| 2025-01-06 | -19.33 |
| 2025-01-03 | -19.68 |